ChAdOx1 COVID-19 vaccine-induced thrombocytopenia syndrome

Abstract

COVID-19 vaccine-induced thrombosis with thrombocytopenia syndrome (TTS) has been reported as a very rare complication after the ChAdOx1 nCoV-19 (AstraZeneca) vaccination and usually manifesting as cerebral venous thrombosis or pulmonary artery embolism. In comparison with stroke and pulmonary embolism, TTS associated intra-abdominal thrombosis is less common. Early identification and timely treatment for TTS are required.